跳至主要内容
临床试验/JPRN-UMIN000006046
JPRN-UMIN000006046已完成未知

Study of High-dose Olmesartan compared with Telmisartan on Blood pressure and Metabolism in Type 2 Diabetics with Hypertension - Study of High-dose Olmesartan compared with Telmisartan on Blood pressure and Metabolism in Type 2 Diabetics with Hypertension

niversity of Occupational and Environmental Health, Japan0 个研究点目标入组 36 人开始时间: 2011年7月31日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
36

研究概览

简要总结

  1. The efficacy of decrease of blood pressure showed no difference between olmesartan and telmisartan. 2)On glucose profiles, olmesartan improved FPG,HbA1c,FIRI and HOMA-IR more effectively than telmisartan. 3)Change rate of hs-CRP is correlated with that of HOMA-IR.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)patients treated with insulin therapy. 2)patients who wrere poorly controlled . 3)patients with secondary hypertension. 4)patients on HD. 5)pregnant patients. 6)patients who wrere allergic to telmisartan and olmesartan. 7)patients with heavy liver dysfunction. 8)patients with heavy renal dysfunction(Cre>3mg/dL).

研究者

发起方
niversity of Occupational and Environmental Health, Japan

相似试验